Suppr超能文献

特应性角结膜炎:老年人的药物治疗。

Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

机构信息

Allergy and Clinical Immunology, Department of Medicine and Surgery, University of Parma, Via Gramsci n.14, 43126, Parma, Italy.

Cardiac/Pulmonary Rehabilitation Unit, ASST Pini-CTO, Milan, Italy.

出版信息

Drugs Aging. 2019 Jul;36(7):581-588. doi: 10.1007/s40266-019-00676-7.

Abstract

Among the different forms of allergic conjunctivitis, atopic keratoconjunctivitis has distinct characteristics, defined by a more common onset in late adolescence or early adulthood, but also affecting the elderly, and with a higher prevalence in male individuals. However, the prevalence of atopic keratoconjunctivitis is scarcely investigated, and the data are often uncertain because other allergic nasal or respiratory disorders occur concomitantly. Mast cells, eosinophils, basophils, and T cells are involved in the pathogenesis of atopic keratoconjunctivitis. Despite its denomination as atopic, negative responses to skin tests or in-vitro immunoglobulin E tests are common. In fact, atopic keratoconjunctivitis can be attributed to a combination of T-helper-1 and T-helper-2 responses, but a higher prominence for T-helper-1 cells was found. The most common symptoms of atopic keratoconjunctivitis are bilateral ocular itching, burning, and tearing with a perennial presentation, although some patients may have seasonal exacerbations in winter or summer. Other symptoms such as photophobia, blurred vision, and mucous chewy discharge, owing to the accumulation of cells and mucin, may occur. The diagnosis of atopic keratoconjunctivitis is mainly clinical, as accepted diagnostic criteria or laboratory tests are not available. The treatment of atopic keratoconjunctivitis is aimed at controlling symptoms, decreasing relapse and exacerbations, and reducing vision loss. Therapeutic options comprise topical ophthalmic drops, including cromones, antihistamines, corticosteroids, and calcineurin inhibitors. Topical ointments are also available for corticosteroids and calcineurin inhibitors. Severe forms may require systemic medications including antihistamines, corticosteroids, and calcineurin inhibitors. Atopic keratoconjunctivitis therapy in the elderly does not differ from the adult population, but the occurrence of multi-morbidities and concomitant drug treatment, which are common in this age group, requires a careful evaluation to determine appropriate and personalized treatment.

摘要

在不同类型的过敏性结膜炎中,特应性角结膜炎具有独特的特征,其发病更常见于青少年晚期或成年早期,但也会影响老年人,且男性发病率更高。然而,特应性角结膜炎的患病率研究甚少,而且数据往往不确定,因为同时存在其他过敏性鼻或呼吸道疾病。肥大细胞、嗜酸性粒细胞、嗜碱性粒细胞和 T 细胞参与了特应性角结膜炎的发病机制。尽管其被称为特应性,但对皮肤试验或体外免疫球蛋白 E 测试的阴性反应很常见。事实上,特应性角结膜炎可能归因于辅助性 T 细胞 1 和辅助性 T 细胞 2 反应的结合,但发现辅助性 T 细胞 1 细胞的作用更为突出。特应性角结膜炎最常见的症状是双侧眼部瘙痒、烧灼感和流泪,表现为常年性,但有些患者可能在冬季或夏季出现季节性加重。其他症状,如畏光、视力模糊和粘性分泌物,是由于细胞和粘蛋白的积聚所致。特应性角结膜炎的诊断主要是临床诊断,因为目前尚无公认的诊断标准或实验室检测方法。特应性角结膜炎的治疗旨在控制症状、减少复发和加重以及降低视力丧失的风险。治疗选择包括局部滴眼剂,包括色甘酸钠、抗组胺药、皮质类固醇和钙调神经磷酸酶抑制剂。皮质类固醇和钙调神经磷酸酶抑制剂也有局部软膏制剂。严重的病例可能需要全身药物治疗,包括抗组胺药、皮质类固醇和钙调神经磷酸酶抑制剂。老年人群的特应性角结膜炎治疗与成人人群并无不同,但该年龄段常发生多种合并症和伴随药物治疗,因此需要仔细评估以确定合适和个性化的治疗方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验